Iradimed Corp. (IRMD) Tops Q2 EPS by 5c, beats revenue

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.36, $0.05 better than the analyst estimate of $0.31. Revenue for the quarter came in at $16.13 million versus the consensus estimate of $15.66 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day